Hyzaar Forte

Losartan potassium, the active ingredient in Hyzaar Forte, is an angiotensin II receptor blocker presented as an oral tablet for systemic use. It is combined with hydrochlorothiazide, a thiazide diuretic, to enhance blood pressure control by reducing fluid volume in adult patients with hypertension.

GNH USA supplies Hyzaar Forte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and other health‑care providers worldwide, ensuring consistent quality, regulatory compliance, reliable logistics and efficient, timely delivery for the global market.

Hyzaar Forte, a combination of an angiotensin II receptor blocker and a thiazide diuretic, is used to manage hypertension.

Essential hypertension: reduces systolic and diastolic blood pressure and lowers cardiovascular risk. Secondary hypertension: assists in controlling blood pressure when an underlying condition contributes to elevated pressure. Hypertension with fluid retention: combines vasodilation and diuresis to improve overall blood pressure control.

Hyzaar Forte may cause a range of adverse reactions.

Common Side Effects: - Dizziness or light‑headedness, especially after the first dose. - Headache. - Increased urination or nocturia. - Fatigue or mild weakness. - Electrolyte disturbances such as low potassium. - Mild gastrointestinal upset.

Serious or Rare Side Effects: - Severe allergic reaction (rash, swelling, difficulty breathing). - Acute kidney injury or worsening renal function. - Hyperkalemia (dangerously high potassium levels). - Significant drop in blood pressure leading to fainting. - Liver enzyme abnormalities. - Pancreatitis.

Before initiating therapy, certain precautions should be considered.

Renal function: monitor serum creatinine and electrolytes in patients with kidney disease. Electrolyte balance: check potassium and sodium levels regularly, especially when combined with other diuretics. Pregnancy: avoid use because safety in pregnancy is not established. Potassium‑sparing agents: do not co‑administer with potassium supplements or potassium‑sparing diuretics to prevent hyperkalemia. Drug interactions: review all concomitant medications for potential additive effects on blood pressure or electrolytes. Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and direct sunlight.

Hyzaar Forte can interact with several medicines.

Major Interactions (Avoid): - Potassium‑sparing diuretics or supplements: risk of dangerous hyperkalemia. - ACE inhibitors or other ARBs combined with aliskiren in diabetic patients: increased renal adverse events. - Lithium: concurrent use may raise lithium levels and cause toxicity.

Moderate Interactions (Monitor Closely): - NSAIDs: may blunt antihypertensive effect and affect kidney function. - Beta‑blockers: additive blood‑pressure lowering; monitor for hypotension. - Non‑thiazide diuretics: may exacerbate electrolyte disturbances; monitor labs.